22nd Century Group News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

29.11.23	22nd Century Appoints Larry Firestone As Chairman, CEO (RTTNews)
28.11.23	22nd Century Group To Sell Hemp/Cannabis Franchise (RTTNews)
05.09.23	22nd Century Group Initiates Process To Evaluate Strategic Alternatives For Its Tobacco Portfolio (RTTNews)
28.07.23	Pre-market Movers: SIGA, SNBR, BLUA, SNTG, PRZO… (RTTNews)
03.07.23	22nd Century Announces 1 For 15 Stock Split; Backs Annual Outlook In Line With Estimates (RTTNews)
16.06.22	22nd Century Group Names Hugh Kinsman As CFO (RTTNews)
29.12.21	FDA genehmigt Vermarktung von VLN® der 22nd Century Group als Tabakprodukt mit modifiziertem Risiko (GlobeNewswire)
24.12.21	FDA Authorizes Marketing Of 22nd Century's VLN As Modified Risk Tobacco Product (RTTNews)
24.12.21	FDA Authorizes Marketing of 22nd Century Group’s VLN® as a Modified Risk Tobacco Product (GlobeNewswire)
30.04.20	22nd Century Group Completes Successful Non-GMO Very Low Nicotine Content Tobacco Research Field Trials (Businesswire)
12.03.20	22nd Century Group, Inc. Files 2019 Annual Report (Businesswire)
07.11.19	22nd Century Group Files 2019 Third Quarter Report (Businesswire)
07.08.19	22nd Century Group Files 2019 Second Quarter Report (Businesswire)
05.08.19	22nd Century Group Appoints Cliff Fleet Chief Executive Officer (Businesswire)
02.08.19	22nd Century Group Announces Conference Call to Provide Business Update (Businesswire)
26.07.19	22nd Century Group CEO to Step Down (Businesswire)
19.07.19	FDA Accepts and Files 22nd Century Group’s Modified Risk Tobacco Product Application for VLN™ Cigarettes (Businesswire)
12.07.19	CDC Survey Finds Most U.S. Adults, including 80% of Smokers, Favor Lowering Nicotine Levels in Cigarettes to Make Them Less Addictive (Businesswire)
14.06.19	22nd Century Group Appoints Michael J. Zercher as Chief Operating Officer (Businesswire)
07.05.19	22nd Century Files 2019 First Quarter Report and Announces Conference Call to Provide Business Update (Businesswire)
30.04.19	22nd Century’s Pre-Market Tobacco Application for VLN™ Cigarettes Advances with Completed FDA Inspection (Businesswire)
18.04.19	Grossly Misleading "Short and Distort” Article Wrongfully Attempts to Dupe 22nd Century Group Shareholders (Businesswire)
17.04.19	22nd Century Group Hires Former Imperial Brands Head of Regulatory Science (Businesswire)
09.04.19	22nd Century Announces Exclusive Worldwide Agreement with KeyGene for Genetic Development of Hemp/Cannabis (Businesswire)
28.03.19	22nd Century Group Issues Annual Letter to Shareholders (Businesswire)
27.03.19	22nd Century’s New Study Confirms Very Low Nicotine Content Cigarettes Result in 97% Less Nicotine in Smoker’s Bloodstream (Businesswire)
06.03.19	22nd Century Files 2018 Annual Report and Announces Conference Call to Provide Business Update (Businesswire)
06.03.19	5 Top Losers In Healthcare Sector (ADMS, PMD, TTOO...) (RTTNews)
28.12.18	22nd Century stellt Antrag bei der FDA für Tabakprodukt mit modifiziertem Risiko (MRTP) bezüglich seiner Zigaretten mit sehr niedrigem Nikotingehalt (Businesswire)
27.12.18	22nd Century Files Modified Risk Tobacco Product (MRTP) Application with the FDA for the Company’s Very Low Nicotine Content Cigarettes (Businesswire)
20.12.18	22nd Century’s Low-THC Cannabis sativa L. Research Activities Receive Legislative Boost (Businesswire)
05.12.18	22nd Century Files Premarket Tobacco Application (PMTA) with the FDA (Businesswire)
07.11.18	22nd Century Files 2018 Third Quarter Report (Businesswire)
26.10.18	22nd Century Group Comments on Grossly Misleading "Short and Distort” Article (Businesswire)
12.10.18	FDA Lead Scientist Discusses 22nd Century’s SPECTRUM® Research Cigarettes in Public Webcast (Businesswire)
05.09.18	JAMA Publishes Greatly Anticipated Phase III Study Using 22nd Century’s SPECTRUM® Very Low Nicotine Content Cigarettes (Businesswire)
21.08.18	22nd Century Receives Order for 3.6 Million SPECTRUM® U.S. Government Research Cigarettes (Businesswire)
07.08.18	22nd Century Files 2018 Second Quarter Report (Businesswire)
31.07.18	Washington Examiner Publishes Public Policy Article by 22nd Century’s James Vail and Juan Sanchez Tamburrino, Ph.D. (Businesswire)
24.07.18	Nondaily Smokers Who Switch to 22nd Century’s Very Low Nicotine Content Cigarettes Reduce their Consumption by a Staggering 51% (Businesswire)
17.07.18	22nd Century Announces the Immediate Feasibility of the FDA’s Nicotine Reduction Plan (Businesswire)
11.07.18	22nd Century Reports on New Responses to the FDA’s Nicotine Reduction Plan (Businesswire)
03.07.18	22nd Century Highlights Public Comments to the FDA’s Nicotine Reduction Plan (Businesswire)
26.06.18	22nd Century kündet neue heissluftgetrocknete, nikotinarme und Burley-Tabaksorten ohne GMO an (Businesswire)
26.06.18	22nd Century Announces New Non-GMO, Very Low Nicotine Flue-Cured and Burley Tobacco Varieties (Businesswire)
25.06.18	22nd Century Group Added to Russell 2000, Russell 3000 and Russell Global Indexes (Businesswire)
20.06.18	22nd Century Conducts Three Short-Term Studies in Support of the Company’s MRTP Application to the FDA (Businesswire)
13.06.18	22nd Century Group to be Added to Russell 2000, Russell 3000, and Russell Global Indexes (Businesswire)
04.06.18	22nd Century to Present to Institutional Investors at the Citi 2018 Small & Mid Cap Conference (Businesswire)
29.05.18	Altria, Reynolds, Lorillard, and Philip Morris Ordered to Issue Corrective Statements on Nicotine Addiction; 22nd Century’s Proprietary VLN (TM) Tobacco Called "Minimally or Non-Addictive” (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Kuehne+Nagel Int	201.80	-0.25 %	K V
Swiss Life Hldg	687.20	-0.26 %	K V
Nestle	73.86	-0.32 %	K V
Swisscom	498.60	-0.87 %	K V
Swiss Re	128.35	-0.96 %	K V
Logitech Intl	73.08	-2.33 %	K V
Roche Hldg G	247.50	-2.94 %	K V
UBS Group	26.84	-3.52 %	K V
Part Grp Hldg	1’212.00	-4.68 %	K V
ABB	49.00	-4.89 %	K V

Nachrichten zu 22nd Century Group Inc

Aktien Top/Flop

Meistgelesene Nachrichten